Source: Journal of Asthma, 2008
Authors: Régis Blais, Claudine Laurier, Michèle Paré
Purpose of StudyThe purpose of this study was to assess the impact of feedback letters to physicians and pharmacists on their patient's appropriate use of asthma medication. Research Approach/... Read more
Source: American Journal of Managed Care, 2008
Authors: Joel Lexchin, Barbara Mintzes
ObjectiveThis study was undertaken to compare the recommendations made by the Canadian Common Drug Review (CDR) regarding whether drugs should be listed on provincial and federal formularies with... Read more
Source: International Journal of Health Services, 2008
Authors: Joel Lexchin
More than 80 percent of clinical drug trials in Canada are funded by the pharmaceutical industry. This article evaluates the overall state of clinical trials in Canada and looks at the interplay... Read more
Source: CMAJ, 2011
Authors: John-Michael Gamble, Daniala L. Weir, Jeffrey A. Johnson, Dean T. Eurich
BackgroundCanada's Common Drug Review was implemented to provide publicly funded drug plans (provincial and federal) with a transparent, rigorous and consistent approach for assessing the clinical... Read more
Source: Healthcare Quarterly, 2011
Authors: Tara Gomes, David Juurlink, Rahim Moineddin, Piotr Gozdyra, Irfan Dhalla, Michael Paterson, Muhammad Mamdani
Overdoses and deaths involving prescription opioids are a major public health concern. Recent data from the United States indicate an opioid-related death rate of 6.4 per 100,000 population annually... Read more
Source: Annual Review of Public Health, 2012
Authors: Barbara Mintzes
Since the global withdrawal of rofecoxib (Vioxx) in 2004, concerns about public health effects of direct-to-consumer advertising (DTCA) have grown. A systematic review of the research evidence on... Read more
Régis Blais
Joel Lexchin
Barbara Mintzes
Irfan Dhalla